{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-018244","form_type":"8-K","ticker":"INGN","cik":"0001294133","company_name":"Inogen Inc","filed_at":"2022-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.117698+00:00","generated_at":"2026-06-25T23:25:03.383694+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Inogen Q1 2022 revenue down 7.5% YoY to $80.4M; net loss $0.62 per share","bullets":["GAAP net loss $14.2M ($0.62/share); adjusted loss per share $0.39.","Revenue $80.4M, down 7.5% YoY, up 5.2% sequentially; domestic B2B fell 83.4% to $5.1M.","Gross margin declined 240 bps to 43.5% due to higher materials costs and temporary manufacturing shutdown.","No FY2022 revenue guidance; Q2 revenue expected to improve sequentially and be in line with Q2 2021; expects continued losses.","EU MDR submission for portable oxygen concentrators filed and under review."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-018244","json":"https://secwatch.observer/filing/0001564590-22-018244.json","markdown":"https://secwatch.observer/filing/0001564590-22-018244.md","text":"https://secwatch.observer/filing/0001564590-22-018244.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1294133/000156459022018244/0001564590-22-018244-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1294133/000156459022018244/ingn-8k_20220505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T23:25:03.383694+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}